- Filed
- Nov 6, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Nov 4, 2020 | 34.73M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 34.72M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2020 | 34.31M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 33.91M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 34.06M sh |
| Stock Repurchased | Q3 2020 · Sep 30, 2020 | $0 |
| Stock Repurchased | Q3 2020 · Sep 30, 2019 | $13.73M |
| Capex | Q3 2020 · Sep 30, 2020 | $475K |
| Capex | Q3 2020 · Sep 30, 2019 | $2.1M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2020 | −$6.76M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | −$105.73M |
| Long Term Debt | Q3 2020 · Sep 30, 2020 | $289.33M |
| Long Term Debt | Q3 2020 · Dec 31, 2019 | $277.03M |
| Short Term Debt | Q3 2020 · Sep 30, 2020 | $0 |
| Short Term Debt | Q3 2020 · Dec 31, 2019 | $0 |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $97.98M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $113.01M |
| Stockholders Equity | Q3 2020 · Sep 30, 2020 | $256.02M |
| Stockholders Equity | Q3 2020 · Jun 30, 2020 | $244.11M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | $279.82M |
| Stockholders Equity restated | Q3 2020 · Sep 30, 2019 | $474.55M |
| Stockholders Equity restated | Q3 2020 · Jun 30, 2019 | $493.75M |
| Stockholders Equity restated | Q3 2020 · Dec 31, 2018 | $741.56M |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $161.98M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $214.5M |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $478.33M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $511.41M |
| Current Assets | Q3 2020 · Sep 30, 2020 | $283.37M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $316.57M |
| Total Assets | Q3 2020 · Sep 30, 2020 | $734.36M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $791.23M |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | $0.28 |
| Eps Diluted | Q3 2020 · Sep 30, 2020 | −$0.92 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$0.71 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$7.85 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | $0.28 |
| Eps Basic | Q3 2020 · Sep 30, 2020 | −$0.92 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$0.71 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$7.85 |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $35.66M |
| Sga Expense | Q3 2020 · Sep 30, 2020 | $127.92M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $65.72M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $217.73M |
| Net Income | Q3 2020 · Sep 30, 2020 | $9.7M |
| Net Income | Q3 2020 · Sep 30, 2020 | −$31.47M |
| Net Income restated | Q3 2020 · Sep 30, 2019 | −$23.94M |
| Net Income restated | Q3 2020 · Sep 30, 2019 | −$267.51M |
| Operating Income | Q3 2020 · Sep 30, 2020 | $1.6M |
| Operating Income | Q3 2020 · Sep 30, 2020 | −$28.42M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$18.35M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$252.55M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2020 | $13.34M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2020 | $55.43M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $21.11M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $63.87M |
| Revenue | Q3 2020 · Sep 30, 2020 | $93.11M |
| Revenue | Q3 2020 · Sep 30, 2020 | $210.64M |
| Revenue restated | Q3 2020 · Sep 30, 2019 | $83.81M |
| Revenue restated | Q3 2020 · Sep 30, 2019 | $237.06M |